Tagged with R

Novo Nordisk Europe Many companies that are focused in the diabetes segment have recognised the need to strengthen their operations in emerging markets, due to the increased prevalence of the disease in countries such as Mexico and Brazil. Indeed, Novo Nordisk’s biggest insulin production facility outside of Denmark is in Brazil. Given these…

Bioneer Could you provide our international readers with a profile of Bioneer as it stands today? Bioneer, having a strong basis of technology and experiences in molecular biology since 1992, we have optimized various products we offer from oligonucleotides, siRNA, PCR products, the kits, instruments that are necessary from basic scientific…

Institut Pasteur How would you define the Institut Pasteur’s relationship with the pharmaceutical industry and how it has evolved in recent years? Since its foundation 120 years ago, the Institut Pasteur has had a close relationship with the pharmaceutical industry. I would even say this relationship is in the institute’s own genes.…

Bristol-Myers Squibb The pharmaceutical industry in Asia is undergoing a period of specialization with R&D booming in places like Australia, Singapore and South Korea and manufacturing in places like China, India and now Vietnam – how does Indonesia fit into the overall picture? Indonesia has a number of very strong fundamental, macroeconomic…

Nordic Pharma France Nordic Pharma has been established in the French market since 2002 as one of its first steps towards internationalization. What have been the main milestones and achievements of Nordic in the French market since then? Since our establishment on the French market in 2002, Nordic Pharma has had a number…

Celgene France In only four years Celgene has introduced a number of important products in the French market and is now seen as a preeminent biopharmaceutical company in hematology. As the head of Celgene France’s operations, what were the main milestones of the company since its establishment in the French market in…

Chiesi France The basis of the pharmaceutical business model is changing. Take sales forces for instance, what will be the composition and daily routine? How much mixed media will it require? Currently, there is a schizophrenic state in to the market in between biotechnologies and generics. This is a clear case of…

Lilly France There is a lot of activity in the pharmaceutical industry and France is no exception especially having passed Germany as the major market of Europe over the past year which coincidently, has also been the case for Lilly’s affiliate in France. What role does this group play in the overall…

Minister of Higher Education and Research What has been the contribution of the LRU reform and specifically what has the Creation of Research Centers and Higher Education (PRES) done to establish universities back at the heart of the research strategy in France? French research produces excellent results, but still suffers from a lack of international visibility,…

Stallergenes Can you highlight some of the more recent milestones for Stallergenes? Stallergenes has been successful over recent years for several reasons, the first of which is the growth of the group. On average we have grown 15% meaning in the past decade our sales have quadrupled our turnover. These results…

Quintiles France As Quintiles is present in all major pharmaceutical markets worldwide, what’s the relevance of the French affiliate and what role it plays inside such a globalized organization? France is important to Quintiles not only because it is in itself a major pharmaceutical market itself but also because many of Quintiles’…

Janssen-Cilag France Janssen-Cilag is involved in not only selling its products in France but research and production as well. As France is a leading subsidiary, can you speak to the importance of the market not only in Europe but overall for the group? We are very proud of being the largest Johnson…